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Malaria remains a major global health problem with a need for improved field-usable diag-
nostic tests. We have developed a portable, low-cost digital microscope scanner, capable of
both brightfield and fluorescence imaging. Here, we used the instrument to digitize blood
smears, and applied deep learning (DL) algorithms to detect Plasmodium falciparum
parasites.
Methods
Thin blood smears (n = 125) were collected from patients with microscopy-confirmed P. fal-
ciparum infections in rural Tanzania, prior to and after initiation of artemisinin-based combi-
nation therapy. The samples were stained using the 40,6-diamidino-2-phenylindole
fluorogen and digitized using the prototype microscope scanner. Two DL algorithms were
trained to detect malaria parasites in the samples, and results compared to the visual
assessment of both the digitized samples, and the Giemsa-stained thick smears.
Results
Detection of P. falciparum parasites in the digitized thin blood smears was possible both by
visual assessment and by DL-based analysis with a strong correlation in results (r = 0.99, p
< 0.01). A moderately strong correlation was observed between the DL-based thin smear
analysis and the visual thick smear-analysis (r = 0.74, p < 0.01). Low levels of parasites
were detected by DL-based analysis on day three following treatment initiation, but a small
number of fluorescent signals were detected also in microscopy-negative samples.
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Conclusion
Quantification of P. falciparum parasites in DAPI-stained thin smears is feasible using DL-
supported, point-of-care digital microscopy, with a high correlation to visual assessment of
samples. Fluorescent signals from artefacts in samples with low infection levels represented
the main challenge for the digital analysis, thus highlighting the importance of minimizing
sample contaminations. The proposed method could support malaria diagnostics and moni-
toring of treatment response through automated quantification of parasitaemia and is likely
to be applicable also for diagnostics of other Plasmodium species and other infectious
diseases.
Introduction
Malaria remains a global health burden with over 200 million new yearly cases [1]. Although
the disease incidence has decreased by approximately 10% during the last decade, data indi-
cates that progress has stalled during recent years [1]. As most malaria cases occur in rural
areas [1], the disease burden is caused partly by difficulties in diagnosing the disease. Cur-
rently, multiple techniques exist for malaria diagnostics [2]. Light microscopy assessment of
blood smears to detect Plasmodium parasites remains the diagnostic gold standard [3] and
allows detection and quantification of the various Plasmodium species while also being more
sensitive than rapid diagnostic tests (RDTs) [4]. Disadvantages with microscopy-based testing
include a high level of labour intensiveness, subjectivity [5,6], dependence on the microsco-
pist’s skill and experience [7], requirements in terms of sample preparation and varying sensi-
tivity for lower-level and mixed infections [4]. In addition to microscopy, easy-to-use RDTs
based on lateral flow immunochromatography to detect Plasmodium-specific antigens are
being used to an increasing extent [8]. These RDTs enable rapid diagnostics at the point-of-
care (POC), but have limited accuracy for non-falciparum [2] and low-level infections, do not
allow for quantification of parasites when monitoring treatment response, and remain positive
after treatment initiation, which means that results should ideally be validated by other meth-
ods [4]. Detection of Plasmodium spp. nucleic acid with nucleic acid amplification tests
(NAATs) has superior analytical sensitivity compared to other methods, especially for mixed
infections [9], and allows quantification of parasitaemia (by real-time quantitative polymerase
chain reaction; qPCR) but is more technically demanding, expensive and therefore not widely
available [4], although certain NAAT-methods, such as loop-mediated isothermal amplifica-
tion (LAMP) show promise as a field-usable techniques [10]. Consequently, the World Health
Organization (WHO) currently recommends microscopy-based methods to confirm diagnosis
in suspected cases of malaria [3]. Various staining methods have been proposed for micros-
copy identification of malaria parasites in blood smears, with Giemsa staining being the stan-
dard method [5]. As visual analysis of blood smears is time-consuming and subjective,
fluorescent staining methods have been proposed to facilitate the sample analysis process [11].
Cell-permeable fluorescent stains can be used to visualize the intracellular Plasmodium para-
sites more clearly and at lower magnification [12] to reduce the need for high-power micros-
copy equipment. Fluorescent stainings can also be combined with brightfield staining
protocols [11]. As access to microscopy diagnostics is severely limited in many areas, the
potential to utilize optical components from widely-available consumer electronic products
(such as smartphone cameras) to create digital microscopes has been recognized [13–15]. By
utilizing miniaturized, low-cost optomechanical components, several devices for POC
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digitization of microscopy slides have been developed. Compared to larger-sized, laboratory-
grade slide scanners, these types of devices can be manufactured significantly cheaper [16] and
have other potential advantages, such as a smaller physical size for increased portability, which
make them potentially more suitable for POC usage. Although these components are signifi-
cantly less expensive than those used in high-end alternatives, the imaging performance
achievable is sufficient to e.g. visualize pathogens in common infectious diseases [17] and for
analysis of histological samples [18]. Digitization of samples at the POC combined with the
mobile connectivity of the instruments also mean that samples can be uploaded to a cloud
server for remote access and analysis using digital methods [19]. Multiple approaches have
been studied for automated, computer-assisted diagnosis of malaria using both traditional
computer vision methods and more recently machine learning algorithms based on deep con-
volutional neural networks [20–22]. Several efforts have been made to digitize blood smears
for malaria diagnostics with POC slide scanners, but a significant challenge with convention-
ally-stained samples is the need for higher magnifications than what is typically supported by
these platforms [21].
In this proof-of-concept study we describe how thin blood smears acquired in field-settings
in Tanzania, stained with the 40,6-diamidino-2-phenylindole (DAPI) fluorophore and scanned
using a low-cost POC digital microscope scanner prototype enables visualization of P. falcipa-
rum parasites. P. falciparum is both the most prevalent malaria parasite in Africa, and the
cause of the vast majority of malaria-related deaths [1]. By digitizing both brightfield and fluo-
rescent image channels from blood smears, and combining them into hybrid images, intracel-
lular malaria parasites can be visualized in the digital samples. Furthermore, we train and
apply two separate deep-learning algorithms to automatically detect and quantify P. falciparum
trophozoites in the digital samples. Results are compared to the visual analysis of the digital
samples and to expert microscopy of Giemsa-stained thick smears, using samples collected on
the day of initiation of artemisinin-based combination therapy (ACT) and three days after
treatment initiation.
Materials and methods
Acquisition and preparation of samples
We acquired 125 thin blood films for this study, which were collected as part of the trial by
Mhamilawa et al. [23]. The samples were pseudonymized with study numbers before being
accessed by the researchers. The overall study workflow and sample analysis process is illus-
trated as a STARD diagram in the supplementary material (S4 Fig). The samples were collected
in a region with moderate levels of malaria transmission where P. falciparum is the predomi-
nant species (Bagamoyo District, Tanzania) during a time-period between July 2017 and
March 2018. Samples were collected from volunteering patients who fulfilled the inclusion cri-
teria (age between 1 and 65 years, history of fever in the last 24 hours or axillary
temperature� 37.5˚C, microscopy-confirmed uncomplicated P. falciparum monoinfection
and written informed consent obtained). Microscopy confirmation of malaria positivity was
performed on separate Giemsa-stained thick blood smears by certified professional microsco-
pists. The number of asexual parasites and gametocytes was determined by counting the num-
ber of visible parasites per 200 white blood cells (WBCs) using a hand tally counter. The
parasite density, measured as the number of asexual parasites per microliter (μl) of blood, was
estimated by dividing the number of detected asexual parasites per by the number of WBCs
counted (200) and multiplying the value by the assumed WBC count μl of blood (8,000 WBC/
μl). A blood smear was considered negative after examining 100 high-power fields or counting
500 WBC with no parasites seen. Each slide was read by two independent and experienced
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microscopists, and upon disagreement on presence of parasites or if density differed by more
than 25%, the slides were subjected to a third independent and decisive reader (blinded to the
results from the previous readers). The mean parasitemia of the two most concordant readings
were used as final parasite densities. In total, 125 unstained thin blood films from 100 separate
patients were obtained for this study. 100 of these samples were collected before initiation of
artemisinin-based combination therapy (ACT) (Day 0), and 25 samples were follow-up thin
blood smears collected three days after initiation of ACT (Day 3). The Day 3 samples were also
analysed by light microscopy examination, according to the procedure described above. Sam-
ples were fixed with methanol (water < 3%) by incubating for approximately 20 minutes at
room temperature, and stored in slide boxes following this. For the staining of the samples, the
slides were initially rinsed with deionized water, after which staining of the samples was per-
formed using a mounting media solution containing 4’,6-Diamidino-2-phenylindole (DAPI)
fluorescent stain (Fluoroshield with DAPI, Sigma-Aldrich Finland Oy, Espoo, Finland). DAPI
is a primary stain for DNA and RNA which penetrates cellular membranes to stain the DNA
(and RNA) of the Plasmodium parasites inside intact erythrocytes. The DAPI staining solution
was applied to the sample and distributed over the surface of the glass slide. Following this, the
sample was let to stand at room temperature for five minutes, after which a cover slip was care-
fully applied to the sample to avoid air bubbles. After staining, the quality of the sample was
examined visually with a fluorescence microscope to confirm that the staining quality was ade-
quate for analysis (i.e. visible fluorescent WBCs to confirm successful staining and low
amounts of debris).
Digitization of slides
For the digitization of the samples we used a prototype of a portable, digital microscope scan-
ner, developed and patented by the University of Helsinki (Helsinki, Finland) for POC scan-
ning of biological samples (Fig 1). The device supports brightfield and fluorescent imaging
of glass slides and scanning of sample areas measuring multiple fields of view (FOVs), by cap-
turing and stitching together multiple FOVs in a similar way as conventional whole-slide
microscopy scanners. The device is constructed using inexpensive plastic optomechanical
components from consumer electronic products. Total material costs for the components are
comparable to the price of a mid-range smartphone (approximately 600–1200 USD), and
Fig 1. Prototype point-of-care digital slide scanner. (a) The prototype digital slide scanner (1) with slide adjustment motor unit
(2) and laptop computer used to control device (3). (b) USAF standardized resolution test chart, digitized with the microscope
prototype, showing the smallest set of resolvable bars (corresponding to a spatial resolution of 0.9 μm).
https://doi.org/10.1371/journal.pone.0242355.g001
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significantly lower than the prices of conventional slide scanners with device costs typically
between 50,000 to 300,000 USD [16]. Notably, similarly to other digital slide scanners, the
operation of the device requires a computer (equipped with USB), which price is not included
in this approximation.
Digital images are captured using a camera module typically used in smartphone camera
systems (See3CAM_130, e-con Systems Inc., St Louis, USA), featuring a 13-megapixel (maxi-
mum resolution 4208 x 3120 pixels) complementary metal oxide semiconductor (CMOS) sen-
sor with a plastic f/3.2” lens. A white light-emitting diode (LED) is used as the light source for
brightfield imaging and an ultraviolet LED combined with a retractable band pass filter for
fluorescent imaging (peak wavelength 365 nm). If the FOV is digitized using both the bright-
field and fluorescence modes of the microscope, the resulting image can be rendered into a
single merged image (Fig 2).
With the current image sensor and lens, the pixel size was 0.22 μm and the spatial resolution
0.9 μm, as measured using a standardized USAF resolution test chart and white-light LED illu-
mination (Fig 1). One sensor FOV measures 0.22 mm2, which is approximately five times
larger than the FOV of a typical 100x objective (0.22mm2 compared to 0.04mm2).
The device is connected to and operated from a computer by universal serial bus (USB),
which also provides power for the device. An external motor unit (Fig 2) is used to move the
sample holder with the glass slide to scan the sample. Coarse focus can be adjusted with a man-
ual focus lever and fine focus with the built-in autofocus routine of the camera module. The
device is controlled with a custom software written in the matrix laboratory (MATLAB, Math-
Works Inc, Natick, MA) computing and programming environment, which features a live
view from the camera feed, overview of scanned areas and controls for adjusting parameters of
Fig 2. Digitized thin blood smear. Microscopic field of view (FOV), showing the corresponding (a) brightfield, (b)
fluorescence and (c) merged thin blood smear digital images. Red bounding boxes showing enlarged areas with (1)
infected red blood cells (RBCs), (2) normal RBCs, (3) leukocytes and (4) fluorescent debris.
https://doi.org/10.1371/journal.pone.0242355.g002
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slide scanning (e.g. area to be captured, focus and exposure). Digitization of areas measuring
more than one FOV utilizes the motor unit for automatic slide translation while the camera
captures multiple images. The individual digitized samples in this study measured 12–20
FOVs per sample, representing a thin smear area (red blood cell [RBC] monolayer) without
significant amounts of artefacts or debris when examined visually) of 2.65–4.41 mm2. This cor-
responds to approximately 80–140 optical microscopy FOVs, using a conventional 100 x mag-
nification [24]. Image files were saved locally in the Tagged Image File Format (TIFF) and
converted to a wavelet file format (Enhanced Compressed Wavelet, ECW, ER Mapper, Inter-
graph, Atlanta, Georgia) with a compression ratio of 1:9, before uploading to the image man-
agement platform (Aiforia Cloud, Aiforia Technologies Oy, Helsinki, Finland). This amount
of compression has been shown in earlier studies to preserve sufficient detail to not alter results
significantly [25]. Remote access to the image server for sample viewing is established using a
web browser, secured with Secure Socket Layer (SSL).
Visual analysis of digital samples and training of deep-learning systems
Samples were visually evaluated by two researchers (O.H. and S.S), who independently
reviewed the digital samples on an LCD computer monitor and counted all visible Plasmodium
parasites in the images. Parasites were manually annotated on the slide-management platform
and the annotations served as ground truth for the digital image analysis. Sample parasitaemia
was calculated as the number of detected parasites divided by the number of red blood cells
(RBCs) detected by digital image analysis as described below. Results were recorded in a
spreadsheet table (Microsoft Excel, Microsoft, Redmond WA).
For the digital analysis of the samples we trained two separate image analysis algorithms,
based on deep learning (DL) with deep convolutional neural networks (CNNs). We utilized
manually annotated image regions (n = 1,176) from a subset of thin blood smears (n = 25) to
train the algorithms to detect visible malaria trophozoites and RBCs. A summary with compar-
ison of the main features and differences of the algorithms is available in the supporting infor-
mation (S1 File).
For the first deep-learning system (DLS 1), the digitized samples were uploaded to a com-
mercially available, cloud-based machine-learning platform (Aiforia Cloud and Create, Aiforia
Technologies Oy, Helsinki, Finland). Using this platform, a supervised deep-learning system
(DLS) was trained to detect intracellular trophozoites in the digital images. For this method,
the corresponding brightfield and fluorescence image channels were merged into hybrid
images (Fig 3). The training data was visually reviewed by a researcher (S.S.), and visible tro-
phozoites and RBCs were annotated to constitute the training data. This system consists of two
sequential CNN algorithms. The first algorithm detects all RBCs (i.e. infected and non-
infected). The corresponding results are then forwarded to a second layer, containing two sep-
arate algorithms; one that detects infected RBCs (RBCs with visible fluorescent intracellular
trophozoites; i.e. parasite candidates) and one that detects non-infected RBCs (RBCs without
visible parasite candidates). The sample parasitaemia is calculated as the number of detected
parasites divided by the total number of detected RBCs (Fig 2). To increase the generalisability
of the model, digital image augmentations by perturbation of the training data were utilized.
In the first CNN layer, augmentations used were rotation (0–360˚), variation of scale (±10%),
shear distortion (±10%), aspect ratio (±10%), contrast (±10%), white balance (±10%) and
luminance (±10%). In the second layer, the training material was augmented by rotation (0–
360˚), variation of scale (±5%), shear distortion (±5%), aspect ratio (±5%), contrast (±5%),
white balance (±5%) and luminance (±5%). Training of the model was performed with 7,584
completed iterations (training epochs) of training and a predetermined feature size for object
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classification of 7 μm (RBCs) and 3 μm (parasites), using an image analysis window size
(FOV) of 15 μm.
The second deep-learning system (DLS 2) analysis method also utilizes deep learning with
CNNs, and analyses the brightfield and fluorescence images from the sample separately. The
workflow of this system is described in Fig 4. First, the RBCs in the brightfield-only image are
identified using circle Hough Transform (CHT) to allow the selection of individual, well-pre-
served RBCs, while avoiding overlapping, clumped or otherwise deformed cells. Subsequently,
a normalized cross correlation and peak finding algorithm [26] identifies the locations match-
ing with a parasite template in the corresponding fluorescence-only image where the correla-
tion peaks represent the centroids of the parasite candidates. Selected RBCs are then used to
create a quantitation mask, and by combining the data from both images the parasite candi-
dates are then addressed to the selected individual RBCs in the merged image. Notably, only
the detected fluorescence signals emitted from locations inside the RBCs are included (with a
small margin to cover the applique parasite forms and possible optical misalignment of the
image channels). This also enables the detection of multiple objects within a single RBC; such
as multiple visible parasites. A threshold was determined for the cross-correlation coefficient
and Structural Similarity Index (SSIM) [27] value of the candidates to reduce computation
cost by not including the least likely parasite objects, i.e. weak signals emitting from the back-
ground fluorescence. The SSIM Index assesses the visual impact of luminance, contrast and
structure characteristics of an image.
For the classification part, transfer learning [28] was utilized using a pre-trained GoogLeNet
network [29] The model is a binary-classification CNN which was trained using manually
selected image-regions from the training series of samples, representing visible parasites and
non-parasite fluorescent objects (i.e. debris and other artefacts). The training data was visually
Fig 3. Training of deep-learning system 1 and analysis of blood smear. Workflow for training of the first deep-
learning system (DLS 1) and subsequent analysis of samples using the trained model. (a): Training of the DLS was
performed on merged images (brightfield and fluorescent images combined) where regions with visible red blood cells
(RBCs) and trophozoites (parasites) were manually annotated and used to train the DLS to detect RBCs and classify
them as infected vs. non-infected. (b): Analysis of samples in the validation series was performed on merged images in
two steps: 1) Segmentation of all visible RBCs and 2) quantification of infected and non-infected RBCs to determine
overall level of parasitaemia.
https://doi.org/10.1371/journal.pone.0242355.g003
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reviewed by a researcher (A.S.), and visible trophozoites (n = 5059) and other fluorescence sig-
nals (n = 856) were annotated from the training samples to constitute the training data for the
two classes. As the parasitaemia level was relatively high in a large part of the training samples,
the number of true parasites was significantly higher than the number representing other fluo-
rescence signals. To reduce training imbalance and to ensure that high-parasitaemia samples
would not dominate the training while preserving a sufficiently diverse distribution of para-
sites, the number of parasites selected from each training sample was limited based on the
SSIM value of the candidate objects. Specifically, in each training sample, only the candidates
with a unique SSIM value were included in the training. Rotation (0–360˚) and variation of
scale (± 5%) were utilized to augment image data, to prevent overfitting. Training of the model
was performed in 30 training epochs with a batch size of 32 using a stochastic gradient descent
solver with a momentum of 0.9 and initial learning rate of 0.0003. During the analysis phase
the RBC was marked infected if at least one addressed parasite candidate was classified as a tro-
phozoite with a classification score of at least 95/100. The overall parasitaemia was determined
by the ratio of infected RBCs to the total number of RBCs (S1 Fig). DLS 2 is run locally and
therefore suitable for potential integration directly into the imaging system for rapid analysis.
Statistical analysis
Statistical analysis of results was performed using a general-purpose statistical software pack-
age (Stata 15.1 for Mac, Stata Corp., College Station, TX, USA). We calculated a Pearson’s
product-moment correlation to determine the relationship between parasitaemia determined
by visual examination and analysis with the deep learning models in the digital samples. We
utilized a two-sided paired Wilcoxon Signed-Rank test to assess the difference in detected lev-
els of parasitaemia between the Day 0 and Day 3 samples. Power analysis for these calculations
were conducted using the G�Power software v3.1.7 (Universität Kiel, Kiel, Germany) to deter-
mine a sufficient sample size, using an alpha of 0.05, a power of 0.95 and an effect size of 1.17
(as calculated based on the difference between visually-determined levels of parasitaemia in
slide pairs from the training data), which yielded a minimum required number of samples of
34 (17 slide pairs) [30].
Ethical statement
The study was conducted in accordance with the Declaration of Helsinki on Good Clinical
Practice. Ethical clearance for the study was issued by the National Institute for Medical
Research (NIMR/HQ/R.8a/Vol.IX/2477) and Muhimbili University of Health and Allied Sci-
ences, Tanzania, (MU/DRP/ERP/Vol.IX/174) and the original clinical trial registered on clini-
caltrials.gov (Identifier: NCT03241901). Written informed consent was obtained from the
study participants prior to enrolment in the study.
Results
Quantification of parasites in digital samples
Prior to analysis of the main samples used in the study, we tested the image capture and algo-
rithms on a series of test blood thin smears, prepared in laboratory conditions from blood
Fig 4. Training of deep-learning system 2 and analysis of blood smear. Workflow of training and analysis with the
second deep-learning system (DLS 2) using the GoogLeNet model. Panels showing brightfield images with segmented red
blood cells (RBCs), the corresponding fluorescence image with detected parasite candidates, classification of parasites and
exported analysis results.
https://doi.org/10.1371/journal.pone.0242355.g004
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cultures with known levels of P. falciparum infection (n = 7; approximately 0%, 0.2%, 0.5%, 1%
and 2%, respectively). Here, we confirmed that fluorescent parasites and parasitized red blood
cells (RBCs) could be visualized at the spatial resolution provided by the instrument. Overall,
we observed a high level of similarity and almost perfect correlation between the DLS-based
sample analysis and the known infection levels of the samples (r(7) = 0.99, p< 0.001) (S4 Fig).
For the samples used in the study, after exclusion of samples used for the training of the
deep-learning systems, 97 samples remained in the validation series, of which 77 samples were
thin blood smears collected at baseline, prior to initiation of treatment with ACT (Day 0), and
20 samples were follow-up thin blood smears collected on day 3 after treatment initiation (Day
3). All samples collected on day 0 were confirmed as malaria-positive by light-microscopy
assessment of thick smears from the same patients, with a mean parasitaemia of 58,711 para-
sites/μL (95%CI 44,055–73,368 parasites/μL) and correspondingly a mean estimated parasitae-
mia of 1.17% (95% CI 0.88–1.47). The follow-up samples on day 3 after treatment initiation
were all confirmed microscopy negative for malaria (no visible parasites in the Giemsa thick
smear). The visual analysis of all fluorescently-stained digitized day 0 thin smears revealed visi-
ble parasites, with an overall mean rate of infected RBCs of 1.79% (CI95% 1.31–2.26%). The
visual analysis of the Day 3 digital samples detected a significantly lower rate of infected RBCs
(0.014%, 95%CI 0.009–0.009–0.020%, z = - 3.92, p< 0.001). The DLS analysis of the digitized
thin smears returned similar levels of detected infected RBCs as the visual analysis of the digital
samples in all analysed microscopy-positive samples (mean 1.70% [95%CI 1.27–2.15%] and
1.76% [95% CI 1.32–2.20%]) (Table 1).
The results from the DLS analysis of the Day 3 digitized thin smears also yielded similar val-
ues as the visual sample analysis (mean 0.05% [95%CI 0.017–0.083] and 0.05% [95%CI 0.009–
0.094]). When assessing correlation between the DLS analysis and the visual analysis of the
digital samples, an almost perfect correlation in detected rate of trophozoites was observed, as
calculated with the Pearson’s product-moment correlation coefficient, for the microscopy-
Table 1. Results from analysis of blood smears with the different methods.
Diagnostic comparison Visual analysis of digitized
thin smears
DLS1 analysis of digitized
thin smears





Number of samples 77 77 77 77
Mean number of parasites detected per
analysed area (n, 95% CI)
398 (297–498) 396 (295–496) 348 (261–436) n/a�
Percentage of infected RBCs (%, 95% CI) 1.79 (1.31–2.26) 1.70 (1.27–2.15) 1.76 (1.32–2.20) 1.17 (0.88–1.47)
Mean estimated parasitemia (trophozoites/
μL, 95% CI)
89,500 (65,500–113,000) �� 85,000 (63,500–107,500) �� 88,000 (66,000–110,000) �� 58,711 (44,054–73,368)
Day 3
Number of samples 20 20 20 20
Mean number of parasites detected per
analysed area (n, 95% CI)
3 (2–4) 11 (4–17) 9 (2–16) 0
Percentage of infected RBCs (%, 95% CI) 0.01 (0.01–0.02) 0.05 (0.02–0.08) 0.05 (0.01–0.09) 0
Mean estimated parasitemia (trophozoites/
μL, 95% CI)
500 (500–1,000) �� 2,500 (1,000–4,000) �� 2,500 (500–4,500) �� 0
Results from analysis of blood samples by light microscopy of Giemsa-stained thick smears, visual analysis of digitized DAPI-stained samples and DLS-based analysis of
the digitized DAPI-stained samples. Parasitaemia estimated as the rate of infected red blood cells (RBCs), multiplied by the assumed number of RBCs per μl of blood
(5,000,000).
�Not available from thick smear analysis.
��Calculated based on the commonly-used approximation of 5,000,000 RBCs per μL.
https://doi.org/10.1371/journal.pone.0242355.t001
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positive samples (r (77) = 0.9996 and 0.9986, p< 0.01), by analysis with DLS 1 and DLS 2.
Compared to the estimated rate of infected RBCs in the Giemsa thick-smear analysis, the cor-
relation for the DLS 1 and DLS 2 results were strong (r (77) = 0.740, p<0.01 and r (77) =
0.743, p< 0.01, respectively) and for the detected rate of infected RBCs in the microscopy-neg-
ative samples, a modest correlation was observed for the DLS-based analysis of samples, com-
pared to the visual sample analysis (r(20) = 0.61 and 0.42, p< 0.01) (Fig 5 and Fig 6).
Fig 5. Detected level of parasitemia by the different methods. Box plots illustrating the detected levels of P.
falciparum parasitemia (percentage of infected red blood cells; RBCs) in malaria-positive blood smears collected prior
to initiation of treatment (Day 0) by the deep learning systems (DLS) and by visual analysis of the digital, DAPI-stained
slides and by conventional light microscopy of Giemsa-stained thick smears.
https://doi.org/10.1371/journal.pone.0242355.g005
Fig 6. Correlation between detected levels of parasitemia by deep learning-based and visual sample analysis.
Correlation between levels of P. falciparum parasitemia, as detected with the deep learning systems (DLSs), and by
visual analysis of the digital samples, collected on (a) Day 0 and (b) Day 3).
https://doi.org/10.1371/journal.pone.0242355.g006
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To further evaluate the DLS-based quantification of P. falciparum parasitemia in the Day 0
samples, we also compared the results from the digital analyses to the level of infection, as
determined by quantitative PCR (qPCR). Here, we also observed a strong correlation between
the DLS- and the qPCR-based assessment of infection level (r(27) = 0.90). As qPCR results
were only available for a subset of patients (27), these are provided in more detail as supple-
mentary material (S2 Fig).
Monitoring of parasite clearance in thin smears collected at the day of ACT
treatment initiation and three days later
After exclusion of samples used for training of the image-analysis systems, 40 samples, con-
taining a total number of 20 pairs of thin smears (Day 0 and Day 3) remained. By expert light
microscopy assessment of the Giemsa-stained thick smears from the same patients, all Day 0
samples (n = 20) were classified as positive for P. falciparum parasites, and all Day 3 (n = 20)
samples classified as negative for visible parasites. Overall, assessed rates of infected RBCs in
the Day 3 samples were significantly lower with all methods studied, than the rates detected in
the pre-treatment (Day 0) samples and the results showed high correlation between the meth-
ods studied (Table 1). A Wilcoxon signed-rank test revealed that the post-treatment (Day 3)
parasitaemia of the digitized DAPI-stained samples was significantly lower than the pre-treat-
ment parasitaemia (Day 0), as determined by visual analysis (mean: 0.01% [95%CI: 0.01–
0.02%] vs. 1.76% [CI 95: 1.32–2.20], z = -3.92, p< 0.001), analysis by DLS 1 (mean: 0.05% [CI
95% 0.02–0.08] vs. 1.70% [CI 95% 1.27–2.15%], z = -3.92, p< 0.001) and analysis by DLS 2
(mean: 0.05% [CI 95% 0.01–0.09) vs. 1.76% [CI 95: 1.32–2.20], z = -3.92, p< 0.001) (Fig 7).
Discussion
In this study we acquired thin blood smears from patients with light microscopy-determined
uncomplicated P. falciparum infection, collected at baseline before initiation of artemisinin-
based combination therapy (ACT) and three days following treatment initiation. We stained
Fig 7. Detected levels of parasitemia on Day 0 and Day 3, following initiation of treatment. Box plots illustrating
the detected levels of P. falciparum parasitemia (percentage of infected red blood cells; RBCs) in blood smears collected
at baseline, prior to initiation of treatment (Day 0) and three days following initiation of treatment (Day 3). Results
shown as detected by analysis with the deep learning systems (DLS) and by visual analysis of the digital slides.
https://doi.org/10.1371/journal.pone.0242355.g007
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the samples using a simplified fluorescent staining protocol and digitized both the fluorescence
and brightfield images into hybrid digital samples, using a small-sized POC digital microscope
prototype. The digital samples were uploaded to a cloud-server and analysed with two deep
learning-based systems to detect and quantify malaria parasites in the samples. Results were
compared to visual assessment of the digitized samples, and to light microscopy examination
of Giemsa-stained thick smears. Overall, we observed strong correlations in the numerical
results, i.e. values for detected level of parasitaemia with the DLS-based system in malaria-posi-
tive samples and visual assessment of the digital samples (r = 0.98–0.99, p< 0.01) and
(r = 0.42–0.61, p< 0.01).
Compared to the light-microscopy assessment of Giemsa-stained thick smears, the correla-
tion in detected number of parasites was strong but lower (0.74, p < 0.01), likely as the quanti-
fication of parasites is not directly comparable when using different methods of analysis and
sample types (thick and thin blood films). Notably, previous studies have shown that the visual
approximation of parasite density in especially thick blood films is prone to variations, due to
factors such as reader technique, quality of slides and the random distribution of parasites and
WBCs [31,32]. Here, both DLSs performed with high similarity to the manual assessment of
the digitized thin smears. When assessing parasite clearance by DLS-based analysis of digital
samples collected on Day 3 after initiation of ACT, significantly lower levels of parasite candi-
dates were detected in the samples using the digital methods (0.05% vs. 1.73%, z = -3.92). For
quantification of P. falciparum parasites in malaria-positive samples, both deep learning algo-
rithms performed with high correlation (r > 0.99) to the manual, visual quantification of para-
sites in the digital samples, suggesting that the methods are comparable. Notably, a similarly
high level of correlation was also observed when comparing the results from the DLSs to the
qPCR-based assessment of infection level (r = 0.90), although these results were only available
for a subset of patients (S2 Fig). Overall, the number of detected signals (parasite candidates)
by analysis with the DLSs was low in microscopy-negative samples, and mainly corresponded
to fluorescent artefacts and debris (S3 Fig). The results here suggest that it would be possible to
establish an operative threshold for the DLSs to separate positive and negative samples with
relatively high sensitivity. Here, by using a threshold for positivity of 0.10% (detected level of
parasitemia) for classifying a sample as malaria-positive, the detection of positive samples in
the validation series would be possible with approximately 95% sensitivity and specificity. This
could initially be useful e.g. as a triage system to automatically detect the majority of abnormal
slides, although the accurate detection of low-level infections would require higher sensitivity.
Our results are in line with findings from earlier studies, where fluorescence malaria field
microscopy has shown promise as a field-applicable and inexpensive diagnostic technology
[33]. Similarly to our findings, previous work has suggested that high sensitivity (up to 98%)
and reasonable sensitivity (89%) can be achieved using visual fluorescence field microscopy,
compared to conventional methods, and especially for samples with high levels of parasitaemia
[34]. Previous work has also demonstrated how the digital analysis of DAPI-stained blood
samples, digitized with a 40x objective digital microscope in laboratory conditions, can be
used to quantify levels of parasitaemia and even classify the infection stage of the parasites
[35]. Notably, the principal challenges with equivocal fluorescent particles being detected as
parasites in samples with low levels of parasitemia encountered here has also been described
previously [33]. Although significantly lower amounts of parasite signals were detected in the
microscopy-negative samples, the levels were still relatively high compared to e.g. the detection
limits of conventional Giemsa thick smear microscopy. Therefore, to achieve ideal levels of
sensitivity for primary malaria diagnostics, methods to improve sensitivity for especially low-
level infections are essential. These include steps to minimize sample contaminations to allow
the digitization of large, representative sample areas (i.e. uncontaminated monolayers of
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RBCs). To achieve similar levels of sensitivity as Giemsa thick smear-microscopy and RDTs,
increasing the total sample area analysed (currently ~100 high-power FOVs) or utilizing meth-
ods to increase the amounts of visible RBCs per image field are crucial.
As this work represents a proof-of-concept study, it has certain limitations that need to be
addressed. Firstly, the principal challenge encountered here and the major cause of false-posi-
tive signals in the microscopy-negative samples was the presence of artefacts and debris in the
blood smears, which resulted in fluorescent signals not originating from parasites. Although
the staining process described here is simple to perform, the technique is, similarly to conven-
tional staining methods, prone to contaminations, which was challenging especially in samples
with higher levels of contamination and low parasite densities (S1 Fig). This emphasizes the
need for robust sample processing to ensure usability in field settings. Therefore, although this
technology could potentially facilitate the sample analysis and reduce the need for trained
experts to analyse samples, the staining process is a crucial step which still requires trained per-
sonnel on site. Secondly, here, we compared the parasite quantification in stained thin blood
smears to the microscopy-assessment of thick smears from the patients, and accordingly
observed a certain variation in the estimated infection levels. To determine the correlation to
Giemsa microscopy, the analysis of Giemsa-stained thin blood smears from the same patients
would be the preferred ground truth, which was not available in the current study. Notably,
when testing the algorithms on samples prepared in laboratory conditions with known levels
of P. falciparum infection, a strong correlation (r> 0.99, p< 0.001) was observed in DLS-
detected levels of infection and known parasitaemia (S4 Fig). Lastly, we digitized areas of the
thin smears that contained representative monolayers with minimal amounts of artefacts, but
in a clinical setting, larger representative sample areas would be analysed to improve the sensi-
tivity for lower-level infections.
Conclusion
This proof-of-concept study shows that detection and quantification of P. falciparum parasites
in thin blood smears is feasible, using a simplified fluorescent staining process, an inexpensive,
POC portable slide-scanner and a deep learning-algorithm. As digital microscopy is currently
limited mainly to laboratories with access to high-end digitization equipment, this method
warrants further investigation as a potential novel platform for AI-based, digital malaria
microscopy at the POC. The method can facilitate microscopy diagnostics in field settings and
offer the benefits that digital and automated microscopy is associated with e.g. more objective
and reproducible results, potentially reduced time for needed for sample analysis (compared
to the manual quantification of parasites), and a method that can be used for monitoring of
treatment efficacy through assessment of parasite clearance. Also, the method is likely to be
applicable for different Plasmodium species and other pathogens, especially those where fluo-
rescence microscopy may offer additional diagnostic advantages.
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Supporting information
S1 Fig. Deep learning-based analysis of control samples. Results from deep learning-based
analysis of control samples, prepared from blood cultures in laboratory-conditions with
known levels of P. falciparum infections (0% and approximately 0.2%, 0.5%, 1% and 2% levels
of parasitemia, respectively). Correlation between results measured with the Pearson’s prod-
uct-moment correlation coefficient and showing an almost perfect level of correlation (r(7) =
0.99).
(TIF)
S2 Fig. Deep learning-based determination of parasitemia, compared to assessment by
quantitative PCR. Detected level of malaria infection before initiation of treatment, as deter-
mined by analysis with the deep learning-systems (DLSs), compared to quantitative PCR-
based analysis of samples from a subset of patients. DLS-detected parasitemia calculated based
on an assumed amount of 5,000,000 RBCs per μL of blood. Correlation between results mea-
sured with the Pearson’s product-moment correlation coefficient and showing a high level of
correlation (r(27) = 0.90).
(TIF)
S3 Fig. Digitized Giemsa-stained thin blood smear. Digitized Giemsa-stained thin blood
smear from patient in study cohort. Images showing sample with high amounts of visible arte-
facts and debris.
(TIF)
S4 Fig. Study workflow. STARD diagram of study workflow and sample processing.
(TIF)
S1 File. Comparison of deep-learning systems and generated raw data for article.
(XLSX)
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